Physician profile
Youngwu Kim
NPI 1952797268
$14,404.54
in general payments reported to CMS, 2019-2025
11 companies · $2,218 in 2025
The $2,218 reported for 2025 was more than what 85% of Urogynecology and Reconstructive Pelvic Surgery (Obstetrics & Gynecology) providers received nationally (typical 2025 total: $413).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2021: $2,219 · 2022: $4,235 · 2023: $3,382 · 2024: $2,218 · 2025: $2,218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,671 · Consulting Fee: $3,575 · Travel and Lodging: $572.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,670.86 |
| Consulting Fee | $3,575.00 |
| Travel and Lodging | $572.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,377.10 | 2022-2025 | Interstim, Altaviva |
| Boston Scientific Corporation | $2,276.70 | 2021-2025 | Upsylon, Solyx Sis System, Advantage System |
| Davol INC. | $2,000.00 | 2021 | |
| Hologic Sales and Service, LLC | $1,575.00 | 2023 | Fluent Fluid Management System |
| Intuitive Surgical, INC. | $1,057.96 | 2022 | |
| Axonics, INC. | $901.63 | 2022-2024 | Bulkamid, Axonics |
| Bolder Surgical, LLC | $675.00 | 2023 | Coolseal Generator |
| Abbvie INC. | $224.92 | 2023-2025 | |
| Dilon Technologies, INC. | $137.70 | 2025 | Hemoblast Bellows |
| Medtronic USA, INC. | $131.73 | 2019 | |
| Urovant Sciences INC | $46.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Youngwu Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.